Have a personal or library account? Click to login
Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology Cover

Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology

Forum of Clinical Oncology
Volume 10 (2019): Issue 2 (December 2019)
By: Evangelos Karamitrousis,  Michalis Liontos and  Nikolaos Tsoukalas  
Open Access
|Apr 2020

Authors

Evangelos Karamitrousis

Department of Medical Oncology, Democritus University of Thrace, Alexandroupolis, Greece

Michalis Liontos

Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece

Nikolaos Tsoukalas

tsoukn@yahoo.gr

Department of Oncology, 401 General Military Hospital, Athens, Greece
DOI: https://doi.org/10.2478/fco-2019-0008 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 1 - 1
Published on: Apr 5, 2020
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2020 Evangelos Karamitrousis, Michalis Liontos, Nikolaos Tsoukalas, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 10 (2019): Issue 2 (December 2019)Next article